Faculty

Ammar M. Killu, M.B.B.S.

Clinical Studies

Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia (HEAL-IST) Rochester, Minn.
The purpose of this study is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant inappropriate sinus tachycardia (IST).
Post-Market Real World Outcomes in WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device (HEAL-LAA) Rochester, Minn.
The purpose of this study is to collect real-world outcomes data on WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device in patients who are implanted with the WATCHMAN FLX Pro device in a commercial clinical setting.

A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD) Rochester, Minn. The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with persistent atrial fibrillation as compared to subjects who received an initial treatment with anti-arrhythmic drugs.

(EpiAcc Registry) Percutaneous Epicardial Access Registry (EpiAcc Registry) Rochester, Minn., Jacksonville, Fla.
This study will look at patient and procedural characteristics of those undergoing EpiAcc, as well as outcomes of procedures using EpiAcc.
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION) Rochester, Minn.
The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation following percutaneous catheter ablation for high risk patients with non-valvular atrial fibrillation.
Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY (EASY AF) Rochester, Minn.
The purpose of this study is to assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study (LESS-VT) Rochester, Minn.
The purpose of this study is to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.